Compounds > rebeccamycin
Page last updated: 2024-08-25

rebeccamycin and Benign Neoplasms

rebeccamycin has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forenza, S; Long, BH; Matson, JA; Rose, WC; Vyas, DM1

Reviews

1 review(s) available for rebeccamycin and Benign Neoplasms

ArticleYear
Discovery of antitumor indolocarbazoles: rebeccamycin, NSC 655649, and fluoroindolocarbazoles.
    Current medicinal chemistry. Anti-cancer agents, 2002, Volume: 2, Issue:2

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Carbazoles; Drug Design; Glucosides; Humans; Indoles; Neoplasms; Structure-Activity Relationship

2002

Other Studies

1 other study(ies) available for rebeccamycin and Benign Neoplasms

ArticleYear
BMS and Exelixis target tumor suppression pathways.
    Expert review of anticancer therapy, 2001, Volume: 1, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Cell Death; Clinical Trials as Topic; Disease Progression; Drug Design; Drug Industry; Genes, Tumor Suppressor; Humans; Indoles; Neoplasms

2001